« FDA Approvals - VIVUS to Present at the ThinkEquity Partners 4th Annual Growth | Main | FDA Drafts Regulatory Guidance to Industry and Labs for Group »

Windhover Information's FDA/CMS Summit for BioPharma Executives: Commercial Success in


Windhover Information's FDA/CMS Summit for BioPharma Executives: Commercial Success in the Regulatory Environment; (RedNova)
December 4-5, 2006 JW Marriott Pennsylvania Ave, Washington, DC Windhover Information has announced that Pfizer Inc. Chief Medical Officer Joe Feczco will be among the prominent speakers at the upcoming FDA/CMS Summit, slated for Dec. 4-5 in Washington, D.C.

FDA fines American Red Cross $4.2M (AP via Yahoo! News)
The government said Friday it was fining the American Red Cross a record $4.2 million for violating blood-safety laws. The violations include failing to reject donors who had traveled to malarial areas and allowing blood and related products to be distributed without proper testing, said Margaret Glavin, the Food and Drug Administration's associate commissioner for regulatory affairs.

American Red Cross fined 4.2 mln USD for blood violations (People's Daily)
The U.S. Food and Drug Administration (FDA) announced Friday that the American Red Cross (ARC) is being fined 4.2 million U.S. dollars for violating blood safety laws.
 

©2006 FDA-News.com. All rights reserved.